Your browser doesn't support javascript.
loading
Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma.
Dochi, Hirotomo; Kondo, Satoru; Murata, Takayuki; Fukuyo, Masaki; Nanbo, Asuka; Wakae, Kousho; Jiang, Wen-Ping; Hamabe-Horiike, Toshihide; Tanaka, Mariko; Nishiuchi, Takumi; Mizokami, Harue; Moriyama-Kita, Makiko; Kobayashi, Eiji; Hirai, Nobuyuki; Komori, Takeshi; Ueno, Takayoshi; Nakanishi, Yosuke; Hatano, Miyako; Endo, Kazuhira; Sugimoto, Hisashi; Wakisaka, Naohiro; Juang, Shin-Hun; Muramatsu, Masamichi; Kaneda, Atsushi; Yoshizaki, Tomokazu.
Afiliación
  • Dochi H; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Kondo S; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Murata T; Department of Virology and Parasitology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Fukuyo M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Nanbo A; Department of Molecular and Cellular Virology, National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Sakamoto, Nagasaki, Japan.
  • Wakae K; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Jiang WP; Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
  • Hamabe-Horiike T; Center for Biochemical Research and Education, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Tanaka M; Center for Biochemical Research and Education, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Nishiuchi T; Division of Integrated Omics Research, Bioscience Core Facility, Research Center for Experimental Modeling of Human Disease, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Mizokami H; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Moriyama-Kita M; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Kobayashi E; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Hirai N; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Komori T; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Ueno T; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Nakanishi Y; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Hatano M; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Endo K; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Sugimoto H; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Wakisaka N; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Juang SH; School of Pharmacy, China Medical University, Taichung, Taiwan.
  • Muramatsu M; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kaneda A; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Yoshizaki T; Division of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa, Japan.
Cancer Sci ; 113(8): 2862-2877, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35633182
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Transactivadores / Neoplasias Nasofaríngeas / Infecciones por Virus de Epstein-Barr / Carcinoma Nasofaríngeo Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Transactivadores / Neoplasias Nasofaríngeas / Infecciones por Virus de Epstein-Barr / Carcinoma Nasofaríngeo Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Sci Año: 2022 Tipo del documento: Article País de afiliación: Japón